NovaBay Pharmaceuticals Inc (NBY)
0.71
-0.03
(-3.96%)
USD |
NYAM |
Oct 04, 16:00
0.6996
-0.01
(-1.46%)
Pre-Market: 20:00
NovaBay Pharmaceuticals Shareholders Equity (Annual): 3.314M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.314M |
| December 31, 2022 | 10.55M |
| December 31, 2021 | 10.17M |
| December 31, 2020 | 12.32M |
| December 31, 2019 | 0.973M |
| December 31, 2018 | 4.954M |
| December 31, 2017 | 2.594M |
| December 31, 2016 | 7.101M |
| December 31, 2015 | -5.098M |
| December 31, 2014 | 1.848M |
| Date | Value |
|---|---|
| December 31, 2013 | 8.516M |
| December 31, 2012 | 14.05M |
| December 31, 2011 | 9.344M |
| December 31, 2010 | 10.49M |
| December 31, 2009 | 13.34M |
| December 31, 2008 | 7.345M |
| December 31, 2007 | 14.32M |
| December 31, 2006 | 1.813M |
| December 31, 2005 | 3.252M |
| December 31, 2003 | 0.802M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
0.973M
Minimum
2019
12.32M
Maximum
2020
7.466M
Average
10.17M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 39.70M |
| Oragenics Inc | 3.168M |
| Nanoviricides Inc | 11.46M |